Cited by 890Bone Metabolism and DiseasesBone health and treatmentsBone health and osteoporosis research

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Open access
Plotkin, Lilian I., Weinstein, Robert S., Parfitt, A. Michael, Roberson, Paula K., Manolagas, Stavros C., Bellido, Teresita·1999·Journal of Clinical Investigation

Abstract

Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 10(-9) to 10(-6) M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-alpha, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid-induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci6800

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In MLO/Y4 cells, apoptosis induced by etoposide, TNF-α, or glucocorticoids was prevented by pretreatment with 5-10 ng/mL sCT.

    “Induction of apoptosis in MLO/Y4 cells by etoposide, TNF-␣, or glucocorticoids was prevented by pretreatment of the cells with 5-10 ng/mL sCT.”

    From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [167]

  • The therapeutic effect of calcitonin in diseases such as glucocorticoid-induced osteoporosis may be partly due to inhibition of osteocyte apoptosis.

    “The authors suggest that the therapeutic effect of calcitonin in diseases such as glucocorticoid-induced osteoporosis may be partly due to inhibition of osteocyte apoptosis (167).”

    From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [167]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [2]2. Papapoulos, S. 1996. Bisphosphonates. Pharmacology and use in the treatment of osteoporosis. In Osteoporosis. R. Marcus, D. Feldman, and J. Kelsey, editors. Academic Press. San Diego, CA. 1209-1234.
  2. [4]4. Azria, M., and Avioli, L.V. 1996. Calcitonin. In Principles of bone biology. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan, editors. Academic Press. San Diego, CA. 1083-1097.
  3. [18]18. Nijweide, P.J., Burger, E.H., Klein-Nulend, J., and Van Der Plas, A. 1996. The osteocyte. In Principles of bone biology. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan, editors. Academic Press. San Diego, CA. 115-126.

Cited by

Sorted by citations

Authors
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T.
Affiliations
  • University of Arkansas for Medical Sciences (US)
  • Central Arkansas Veterans Healthcare System (US)
Corresponding author
Bellido, Teresita
Venue
Journal of Clinical Investigation
Published
1999-11-15
Volume
104
Issue
10
Pages
1363-1374
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2170680219
Cited by
890
References
62
Citations by year
2026: 5 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 29 · 2016: 41 · 2015: 26 · 2014: 54 · 2013: 44 · 2012: 40
FWCI
11.43
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ar043003-05)
  • National Institute on Aging (P01AG/AMS13918, P01AG013918)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR43003, R01AR046191)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
bisphosphonates, calcitonin, osteocyte apoptosis, osteoblast apoptosis, glucocorticoid-induced osteoporosis, alendronate, etidronate, pamidronate, extracellular signal-regulated kinase, ERK1/2 phosphorylation, dexamethasone, TNF-α, etoposide, prednisolone, MLO-Y4 cells, trabecular bone
MeSH terms
Pamidronate, Animals, Calcitonin, Cell Line, Cells, Cultured, Dexamethasone, Diphosphonates, Etoposide, Osteoblasts, Osteocytes, Prednisolone, Skull, Etidronic Acid, Tumor Necrosis Factor-alpha, Apoptosis, Alendronate, In Situ Nick-End Labeling, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review